Lurasidone Hydrochloride

A generic pharmaceutical company announced the availability of a schizophrenia and bipolar depression treatment, according to a press release.

Latuda use was associated with statistically significant improvements on individual quality-of-life items compared with placebo among patients with bipolar depression.